No Data
No Data
Kayak, Nile and other emerging market press releases.
Acquisition and subsidiary of Sonic Move, which handles planning for Cloud Works web and application, under stock code 3900. Acquisition and subsidiary of Mega Communications, which handles planning, production, PR, and marketing for Kayak advertising under stock code 3904. Large exercise of subscription rights with modified exercise price clause for Bright Path's 17th issuance, with remaining 2.42 million shares to be granted from 11th onward. Subscription rights mentioned in the 16th issuance with modified exercise price clause.
Emerging Markets Stock Digest: Solasia continues to rise, BUYSELL plunges.
<3907> Silicon Sta, 1007, rising for the third consecutive time. The company's share buyback announced after the close of trade on the 17th was well received. The company said that it will buy up to 0.1 million 3900 shares (3.61% of the total number of issued shares excluding treasury stock) through off-auction own share purchase transactions by the Tokyo Stock Exchange at 8:45 am on the 18th (ToSTNeT-3). The reason for conducting own share acquisition is to enable flexible capital policy to respond to changes in the business environment. On the 18th, the upper limit number of shares will be acquired as planned.
Hot stocks digest (morning session): Toshiba Electronic, Ambis, Solegia, etc.
Career DC <2410>: 1900 yen (+70 yen), a significant increase. They announced on the previous day that they will acquire their own shares in off-hours trading, up to 0.4 million shares or 732 million yen, equivalent to 7.16% of the issued shares. This is intended to improve capital efficiency and pursue a flexible capital policy in order to further return profits to shareholders. They also announced that they had acquired 0.35 million 2700 shares in off-hours trading today. On July 31, they announced that they had acquired 1.55 million 6479 shares of their own stock.
Sorejia - continued rise, announces non-clinical test results related to dose response of SP-05 (alcohol-rich kissoline).
Continuing its rise. After the close of trading on the 17th, non-clinical trial results related to the dosage reactivity of the development product SP-05 (Alhorichikisorin) were announced, which is considered to be good news. Isofol Medical AB, the license introducer, announced two non-clinical trial results demonstrating the dosage reactivity of Alhorichikisorin on July 16, 24 (local time), which further strengthens the hypothesis on the trial design for the Phase Ib/II clinical trial planned to start by the end of 2024, targeting colorectal cancer patients.
Rakuria Pharma, Silicon Studio and others.
<3185> Yumetobou 11th subscription rights (with exercise price adjustment clause) issuance (3.6 million potential shares, raising approximately 55.7 billion yen). <3907> Silicon Studio share buyback, with a limit of 100,3900 shares (3.61% of issued shares), purchased on ToSTNeT-3 on the 18th. <4579> Lakolia's U.S. patent assessment of Nav1.7 and Nav1.8 sodium channel blockers (polycyclic ring inducers). <4597> Solegia's product development SP-05 (a...
MFS, Kudan, and other emerging market companies are subject to the 5% rule.
<196A> MFS Guardian Capital Singapore Private Limited (Gordian Capital Singapore Private Limited) shareholding ratio: -% → 5.05%. Obligation to report ownership occurred on July 5, 2024. <4425> Kudan Inc. Growth Capital Co., Ltd. shareholding ratio: 9.58% → 8.36%. Obligation to report ownership occurred on July 2024.
No Data